Decipher Bladder Genomic Classifier
Use
The Decipher Bladder Genomic Classifier is a novel molecular subtyping tool that facilitates personalized treatment decisions in bladder cancer. It classifies bladder tumors into five molecular subtypes, providing actionable insights that guide treatment plans. It's specifically designed for patients diagnosed with bladder cancer to assess and predict the molecular profile of their tumors, offering information about potential responses to neoadjuvant chemotherapy (NAC) and other treatment intensities. The classifier aids in predicting the risk of cancer upstaging to non-organ confined disease, crucial for planning surgical interventions.
Special Instructions
Not provided.
Limitations
The test is intended for use within the United States under the constraints of existing medical regulations, as it has not received FDA clearance or approval. Its utility is primarily diagnostic and prognostic, without direct therapeutic interventions. The classifier provides subtype classification, which should be integrated into broader clinical assessments and not used in isolation for treatment decisions. Its predictive value is supported by peer-reviewed studies; however, outcomes may vary, and results must be interpreted by qualified healthcare professionals familiar with comprehensive patient histories and concurrent diagnostic data.
Methodology
Microarray (Expression Array)
Biomarkers
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Tumor Tissue (Fresh)
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Ensure proper collection of bladder tumor specimens following biopsy or surgical resection for analysis.
Other tests from different labs that may be relevant